Stem Cell Study Shows Benefits in Treatment of Spinal Injuries
By Nutech Mediworld, PRNEWednesday, November 10, 2010
Results of 108 Patients Demonstrate Safety and Efficacy
SEOUL, South Korea, November 11, 2010 - Dr. Geeta Shroff, founder & medical director of Nutech Mediworld,
presented the summary results of a retrospective clinical study of
human embryonic stem cell (hESC) therapy in patients with chronic spinal cord
injury (SCI). Speaking at the 2nd Annual World Stem Cells & Regenerative
Medicine Congress Asia 2010, Dr. Shroff explained her treatment protocol and
clinical results, demonstrating the safety and efficacy of her human
embryonic stem cell (hESC) therapy. The groundbreaking study was conducted on
108 chronic SCI patients treated by Dr. Shroff over a 6 year period-2004 to
2009. Dr Geeta Shroff also shared her vision, which is to see hESC therapy
available globally as the first line of treatment for many of mankind's worst
afflictions and her willingness to collaborate with entities and work with
regulatory authorities worldwide, to realise this vision.
About the hESC Technology
Dr. Geeta Shroff has developed a commercially viable technology to
isolate hESC, culture them, prepare them for clinical application and store
them in ready-to-use form with a shelf life of six months. This technology,
which has patents applied for worldwide, provides a safe and effective,
'purely human' product, for the treatment of a wide range of medical
conditions. The ready-to-use product is universally acceptable as it does not
require any cross- matching and has a shelf life of 6 months, making it
amenable to global marketing. The technology is being used clinically to
treat many conditions including spinal injuries, multiple sclerosis,
Parkinson's disease, diabetes, Lyme disease, cerebral palsy and autism. Since
2002, more than 800 patients from 35 countries have been treated at Nutech
Mediworld, New Delhi and the number is steadily growing.
For further information, please contact: Nutech Mediworld info@ntmw.net
For further information, please contact: Nutech Mediworld, info at ntmw.net, +91(0)9810061275
Tags: Europe, November 11, Nutech Mediworld, Seoul, South Korea